Mediusa Pharmaceutical Joint Stock Company (Công Ty Cp Dược Phẩm Mediusa) is based in Vietnam. The head office is in Ha Noi (municipality). The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on November 09, 2015. 58 (2023) employees currently work for Mediusa Pharmaceutical Joint Stock Company (Công Ty Cp Dược Phẩm Mediusa). The latest financial highlights indicate a net sales revenue drop of 10.04% in 2024. During that time, Mediusa Pharmaceutical Joint Stock Company (Công Ty Cp Dược Phẩm Mediusa)’s total assets grew by 16.57%. In 2024, Mediusa Pharmaceutical Joint Stock Company (Công Ty Cp Dược Phẩm Mediusa)’s net profit margin decreased by 0.15%.

Headquarters
House Number 78D5, Dai Kim - Dinh Cong Urban Area, Dinh Cong Ward, Hanoi
Ha Noi (municipality); Red River Delta;

Contact Details: Purchase the Mediusa Pharmaceutical Joint Stock Company (Công Ty Cp Dược Phẩm Mediusa) report to view the information.

Basic Information

Total Employees:

Purchase the Mediusa Pharmaceutical Joint Stock Company (Công Ty Cp Dược Phẩm Mediusa) report to view the information.

Financial Auditors:

Purchase the Mediusa Pharmaceutical Joint Stock Company (Công Ty Cp Dược Phẩm Mediusa) report to view the information.

Incorporation Date:

November 09, 2015

Key Executives

Purchase this report to view the information.

Advisor, Chairman

Ownership Details

Purchase this report to view the information.

48%

Purchase this report to view the information.

40%

Purchase this report to view the information.

12%

Company Performance

Financial values in the chart are available after Mediusa Pharmaceutical Joint Stock Company (Công Ty Cp Dược Phẩm Mediusa) report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency VND. Absolute financial data is included in the purchased report.

Net sales revenue

-10.04%▼

Total Operating Revenue

-10.04%▼

Operating Profit

-29.31%▼

EBITDA

-29.31%▼

Net Profit/Loss for the Period

-20.99%▼

Total Assets

16.57%▲

Total Equity

0.96%▲

Operating Profit Margin

-0.43%▼

Net Profit Margin

-0.15%▼

Return on Equity (ROE)

-0.26%▼

Quick Ratio

-34.46%▼

Cash Ratio

-20.73%▼

Mediusa Pharmaceutical Joint Stock Company (Công Ty Cp Dược Phẩm Mediusa) (Vietnam)

Similar companies

Related EMIS Industry Reports